Jane Street’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PLRX
TCM
ACM
MAM
LCM
BCM
Jane Street's PLRX Position: Q2 2026 in Review
Jane Street reduced its Pliant Therapeutics (PLRX) stake by 64% in Q2 2026, selling an estimated $276K and leaving 129,951 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #10359.
Jane Street first reported a position in PLRX in Q2 2020 and has held it in 16 quarters since. The position peaked at $5.92M in Q1 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.
- Jane Street held 129,951 shares of Pliant Therapeutics worth $148K as of Q2 2026.
- Jane Street sold 226,843 Pliant Therapeutics shares in Q2 2026, an estimated $276K.
- Pliant Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10359 holding.
- Jane Street first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 16 quarters since.
- Jane Street's Pliant Therapeutics position peaked at $5.92M in Q1 2023.
- 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.